{
  "id": 13493034,
  "title": "Better Pharma ETF: iShares IHE vs. State Street XPH",
  "url": "https://urgent.news/2026/10/10/better-pharma-etf-ishares-ihe-vs-state-street-xph-13493034",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-10T17:31:01.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/better-pharma-etf-ishares-ihe-vs-state-street-xph"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsThe iShares U.S. Pharmaceuticals ETF is significantly more concentrated than the State Street SPDR S&P Pharmaceuticals ETF, with Eli Lilly accounting for 23.63% of the portfolio.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma",
        "url": "https://urgent.news/2026/10/10/better-healthcare-etf-vanecks-biotech-focused-bbh-vs-state-streets",
        "published": "2026-10-10T16:19:50.000Z"
      },
      {
        "outlet": "Nasdaq Markets",
        "title": "Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma",
        "url": "https://urgent.news/2026/10/10/better-healthcare-etf-vanecks-biotech-focused-bbh-vs-state-streets-13472745",
        "published": "2026-10-10T16:39:50.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}